DXS InternationalAQSE:DXSP Gross Margin % is 86.20% as of Apr. 2025, which is 1% below its 10-year median of 86.71. The stock has 2 warning signs investors should review. Among 630 Healthcare Providers & Services companies, DXS International ranks better than 91.75% on this metric.
The historical rank and industry rank for DXS International's Gross Margin % or its related term are showing as below:
AQSE:DXSP'
s Gross Margin % Range Over the Past 10 Years
Min: 84.09 Med: 86.71 Max: 90.27
Current: 86.2
During the past 11 years, the highestGross Margin % of DXS International was 90.27%. The lowest was 84.09%. And the median was 86.71%.
AQSE:DXSP's Gross Margin % is ranked better than 91.75% of 630
companies
in the Healthcare Providers & Services industry
Industry Median: 40.075
vs AQSE:DXSP: 86.20
DXS International had a gross margin of 86.20% for the quarter that ended in Apr. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for DXS International was -0.80% per year.
DXS International (AQSE:DXSP) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
DXS International had a gross margin of 86.20% for the quarter that ended in Apr. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
DXS International Gross Margin % Related Terms
DXS International Gross Margin % Historical Data
* Premium members only.
The historical data trend for DXS International's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSE:DXSP vs VEEV, BTSG, TEM: Gross Margin % Comparison
For the Health Information Services subindustry, DXS International's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's Gross Margin % distribution charts can be found below:
* The bar in red indicates where DXS International's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
DXS International (AQSE:DXSP) has a Gross Margin % of 86.20% as of Apr. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on DXS International and its competitors. This is near median its historical median of 86.71. Over the past decade, DXS International's Gross Margin % has ranged from 84.09 to 90.27. According to the industry distribution chart, DXS International ranks #52 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 8.3%.
Is DXS International's Gross Margin % too high?
DXS International's current Gross Margin % of 86.20% is near median its 10-year median of 86.71. Over the past 10 years, this metric has ranged from a low of 84.09 to a high of 90.27. The Healthcare Providers & Services industry median Gross Margin % is 40.08. DXS International's value of 86.20% is 115.1% above this industry median. Based on the distribution chart, DXS International ranks #52 out of 630 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does DXS International's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #52 out of 630 companies for Gross Margin %. This places DXS International in the top 8% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 40.08. DXS International's value of 86.20% is 115.1% above this benchmark. Historically, DXS International's own Gross Margin % has ranged from 84.09 to 90.27 over the past decade. While the company's 10-year median is 86.71 vs. the industry median of 40.08, DXS International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.08, based on 630 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DXS International's current Gross Margin % of 86.20% is 115.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current Gross Margin % is 86.20%, which is near median its own 10-year median of 86.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 37.5% below its estimated fair value. The current Gross Margin % is 86.20%, which is near median its 10-year median of 86.71 and 115.1% above the Healthcare Providers & Services industry median of 40.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Gross Margin % is 86.20% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:DXSP has been successfully added to your 